| P2093 | author name string | Reidar Grénman | |
| | Prem Seth | |
| | Risto Ala-aho | |
| | Veli-Matti Kähäri | |
| P2860 | cites work | Biochemical characterization of human collagenase-3 | Q24318765 |
| | The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction | Q24336413 |
| | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| | WAF1, a potential mediator of p53 tumor suppression | Q27861121 |
| | Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene | Q28118453 |
| | Definition of a consensus binding site for p53 | Q28207794 |
| | p53 mutations in human cancers | Q28302973 |
| | Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 |
| | P53, cell cycle control and apoptosis: Implications for cancer | Q28611435 |
| | Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product | Q28645822 |
| | A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia | Q29615437 |
| | Matrix metalloproteinases and their inhibitors in tumour growth and invasion | Q33603385 |
| | Regulation of matrix metalloproteinase expression in tumor invasion. | Q33605726 |
| | Strategies for manipulating the p53 pathway in the treatment of human cancer. | Q34076012 |
| | p53-dependent apoptosis pathways. | Q34305233 |
| | Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector | Q35068584 |
| | Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness | Q35360505 |
| | Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. | Q35745256 |
| | Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor | Q35753232 |
| | Repression of the basal c-fos promoter by wild-type p53 | Q35924458 |
| | Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family | Q36136925 |
| | Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas | Q36617718 |
| | The p53 tumour suppressor gene | Q37751892 |
| | Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter | Q40023735 |
| | Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53 | Q40395907 |
| | Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection | Q40756350 |
| | Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-gamma is associated with activation of extracellular signal-regulated kinase-1,2 and STAT1. | Q40904269 |
| | Human collagenase-3 is expressed in malignant squamous epithelium of the skin | Q42442111 |
| | Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells | Q43844097 |
| | Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma | Q47976180 |
| | p53 regulates the expression of the tumor suppressor gene maspin | Q64380947 |
| | Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase | Q64381116 |
| | Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates | Q70645807 |
| | Degradation of cartilage aggrecan by collagenase-3 (MMP-13) | Q71006880 |
| | p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines | Q71472133 |
| | A fluorescent screening assay for collagenase using collagen labeled with 2-methoxy-2,4-diphenyl-3(2H)-furanone | Q72395803 |
| | Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds | Q73470222 |
| | Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13) | Q73643335 |
| | High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma | Q73828502 |
| | p53 down-regulates human matrix metalloproteinase-1 (Collagenase-1) gene expression | Q77335893 |
| | Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx | Q77924455 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 1187-1195 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells | |
| P478 | volume | 21 | |